Unmet prescription medication need in U.S. children

Sandhya Mehta1, Saurabh Nagar, Rajender Aparasu

  • 1Department of Clinical Sciences and Administration, College of Pharmacy, University of Houston, Texas Medical Center, Houston, TX, USA.

Insights

Over half a million children in the U.S. faced unmet prescription medication needs (UPMN) due to cost, insurance issues, or health plan problems. Addressing racial disparities and ensuring continuous coverage are crucial for improving access to essential medicines for children.

Area of Science:

  • Pediatric Health Outcomes
  • Health Services Research
  • Medication Access

Background:

  • Unmet prescription medication need (UPMN) affects a significant portion of the pediatric population.
  • Understanding the predictors of UPMN is crucial for developing targeted interventions.

Purpose of the Study:

  • To investigate the prevalence and characteristics of UPMN in children.
  • To identify key predictors of UPMN, including cost, health plan issues, and insurance status.

Main Methods:

  • Utilized data from the 2003 National Survey of Children's Health (NSCH), a population-based survey.
  • Employed retrospective cross-sectional survey design with parents/guardians reporting on children's prescription medication use.
  • Applied multivariate logistic regression to analyze predictors of UPMN within the Andersen behavioral model framework.

Main Results:

  • Approximately 0.54 million children (1.23%) experienced UPMN.
  • Higher prevalence observed in Black children, families below 200% federal poverty level, and those with fair/poor perceived health.
  • Cost, health plan problems, and lack of insurance were primary reasons for UPMN, affecting 35%, 27%, and 41% of cases, respectively.
  • Race, poverty, insurance status, perceived health, and depression were significant predictors of UPMN.

Conclusions:

  • Over half a million children in the U.S. experience UPMN, primarily driven by financial and insurance-related barriers.
  • Racial disparities and issues with continuity of health insurance coverage require attention to improve medication access for children.
  • The findings highlight the need for policy interventions to ensure equitable access to prescription medications for pediatric populations.
Abstract

Related Concept Videos

Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...